Purchases and Sales Made in Q3 2024 in Gilead Sciences, Inc. (GILD)
This table provides information about the institutional ownership of Gilead Sciences, Inc. (GILD) during Q3 2024. The information is specifically focused on institutions that hold shares of GILEAD SCIENCES, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-1.3M- 51.02% |
$86.3M - $109M
|
1.24M
$112M
|
|
|
Nov 14, 2024
Q3 2024
|
Apg Asset Management N.V.
Amsterdam, P7 |
SELL
|
- |
-1.31M- 70.07% |
$87.2M - $110M
|
560K
$50.3M
|
|
|
Nov 06, 2024
Q3 2024
|
Kbc Group Nv
|
SELL
|
- |
-1.34M- 37.07% |
$89.5M - $113M
|
2.28M
$205M
|
|
|
Nov 14, 2024
Q3 2024
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-1.59M- 34.64% |
$106M - $133M
|
3M
$269M
|
|
|
Nov 14, 2024
Q3 2024
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-1.84M- 98.21% |
$123M - $155M
|
33.5K
$3.01M
|
|
|
Nov 14, 2024
Q3 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-2.04M- 22.18% |
$136M - $171M
|
7.14M
$642M
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-2.09M- 10.8% |
$139M - $175M
|
17.2M
$1.55B
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-2.6M- 77.8% |
$173M - $218M
|
741K
$66.6M
|
|
|
Nov 14, 2024
Q3 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-2.63M- 79.04% |
$175M - $221M
|
699K
$62.8M
|
|
|
Nov 14, 2024
Q3 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-3.77M- 60.23% |
$251M - $316M
|
2.49M
$224M
|
|
|
Nov 12, 2024
Q3 2024
|
Pacer Advisors, Inc.
Malvern, PA |
SELL
|
- |
-7.11M- 90.09% |
$473M - $597M
|
782K
$70.2M
|